Stromal response to Hedgehog signaling restrains pancreatic cancer progression

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 30, 2014, Pages

  Lee, John J ^a   Perera, Rushika M ^b   Wang, Huaijun ^a   Wu, Dai Chen ^a   Liu, X Shawn ^a   Han, Shiwei ^c   Fitamant, Julien ^b   Jones, Phillip D ^a   Ghanta, Krishna S ^b   Kawano, Sally ^a   Nagle, Julia M ^b   Deshpande, Vikram ^b   Boucher, Yves ^c   Kato, Tomoyo ^a   Chen, James K ^a   Willmann, Jürgen K ^a   Bardeesy, Nabeel ^b   Beachy, Philip A ^a,d  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

Cancer therapy; Cerulein; Hedgehog agonist; Sonic hedgehog; Tumor stroma

Indexed keywords

CERULETIDE; K RAS PROTEIN; SONIC HEDGEHOG PROTEIN; VISMODEGIB;

ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER SURVIVAL; CARCINOGENESIS; COHORT ANALYSIS; CONTROLLED STUDY; HISTOPATHOLOGY; HYPERPLASIA; IN VIVO STUDY; MOUSE; NONHUMAN; PANCREAS ADENOCARCINOMA; PANCREAS ADENOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CANCER THERAPY; CERULEIN; HEDGEHOG AGONIST; SONIC HEDGEHOG; TUMOR STROMA;

ANIMALS; CARCINOMA, PANCREATIC DUCTAL; HEDGEHOG PROTEINS; HUMANS; MICE; MICE, KNOCKOUT; PANCREATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS P21(RAS); SIGNAL TRANSDUCTION;

EID: 84904994417     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1411679111     Document Type: Article

References (51)

1. Howlader N, et al. (2013) SEER Cancer Statistics Review, 1975-2010 (National Cancer Institute, Rockville, MD).
2. Anonymous (2010) StatBite. U.S. pancreatic cancer rates. J Natl Cancer Inst 102(24):1822.
3. Conroy T, et al.; Groupe Tumeurs Digestives of Unicancer; PRODIGE Intergroup (2011) FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 364(19):1817-1825.
4. Von Hoff DD, et al. (2013) Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med 369(18):1691-1703.
5. Hebrok M, Kim SK, Melton DA (1998) Notochord repression of endodermal Sonic hedgehog permits pancreas development. Genes Dev 12(11):1705-1713. (Pubitemid 28299520)
6. Hebrok M, Kim SK, St Jacques B, McMahon AP, Melton DA (2000) Regulation of pancreas development by hedgehog signaling. Development 127(22):4905-4913.
7. Kim SK, Melton DA (1998) Pancreas development is promoted by cyclopamine, a hedgehog signaling inhibitor. Proc Natl Acad Sci USA 95(22):13036-13041. (Pubitemid 28509519)
8. Strobel O, et al. (2010) Pancreatic duct glands are distinct ductal compartments that react to chronic injury and mediate Shh-induced metaplasia. Gastroenterology 138(3):1166-1177.
9. Thayer SP, et al. (2003) Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 425(6960):851-856. (Pubitemid 37355945)
10. Hingorani SR, et al. (2005) Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell 7(5):469-483. (Pubitemid 40719130)
11. Berman DM, et al. (2003) Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature 425(6960):846-851. (Pubitemid 37351469)
12. Yauch RL, et al. (2008) A paracrine requirement for hedgehog signalling in cancer. Nature 455(7211):406-410.
13. Feldmann G, et al. (2008) Hedgehog inhibition prolongs survival in a genetically engineered mouse model of pancreatic cancer. Gut 57(10):1420-1430.
14. Feldmann G, et al. (2007) Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: A new paradigm for combination therapy in solid cancers. Cancer Res 67(5):2187-2196. (Pubitemid 46424238)
15. Feldmann G, et al. (2008) An orally bioavailable small-molecule inhibitor of Hedgehog signaling inhibits tumor initiation and metastasis in pancreatic cancer. Mol Cancer Ther 7(9):2725-2735.
16. Bailey JM, Mohr AM, Hollingsworth MA (2009) Sonic hedgehog paracrine signaling regulates metastasis and lymphangiogenesis in pancreatic cancer. Oncogene 28(40):3513-3525.
17. Tian H, et al. (2009) Hedgehog signaling is restricted to the stromal compartment during pancreatic carcinogenesis. Proc Natl Acad Sci USA 106(11):4254-4259.
18. Nolan-Stevaux O, et al. (2009) GLI1 is regulated through Smoothened-independent mechanisms in neoplastic pancreatic ducts and mediates PDAC cell survival and transformation. Genes Dev 23(1):24-36.
19. Bailey JM, et al. (2008) Sonic hedgehog promotes desmoplasia in pancreatic cancer. Clin Cancer Res 14(19):5995-6004.
20. Olive KP, et al. (2009) Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 324(5933):1457-1461.
21. Fendrich V, et al. (2011) Ectopic overexpression of Sonic Hedgehog (Shh) induces stromal expansion and metaplasia in the adult murine pancreas. Neoplasia 13(10):923-930.
22. Rosow DE, et al. (2012) Sonic Hedgehog in pancreatic cancer: from bench to bedside, then back to the bench. Surgery 152(3, Suppl 1):S19-S32.
23. Anonymous (January 27, 2012) Press release: Infinity reports update from phase 2 study of saridegib plus gemcitabine in patients with metastatic pancreatic cancer. Available at www.businesswire.com/news/home/20120127005146/ en/Infinity-Reports-Update-Phase-2-Study-Saridegib#.UxAvFfRdVxV. Accessed July 2, 2014.
24. Catenacci DVT, et al. (2012) A phase IB/randomized phase II study of gemcitabine (G) plus placebo (P) or vismodegib (V), a hedgehog (Hh) pathway inhibitor, in patients (pts) with metastatic pancreatic cancer (PC): Interim analysis of a University of Chicago phase II consortium study. J Clin Oncol 30(Suppl):Abstract 4022.
25. De Jesus-Acosta A, et al. (2014) A Phase II study of vismodegib, a hedgehog (Hh) pathway inhibitor, combined with gemcitabine and nab-paclitaxel (nab-P) in patients with untreated metastatic pancreatic ductal adenocarcinoma (PDA). J Clin Oncol 32(Suppl):257.
26. Hingorani SR, et al. (2003) Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 4(6):437-450. (Pubitemid 38050041)
27. Jensen JN, et al. (2005) Recapitulation of elements of embryonic development in adult mouse pancreatic regeneration. Gastroenterology 128(3):728-741. (Pubitemid 40585375)
28. Kopp JL, et al. (2012) Identification of Sox9-dependent acinar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma. Cancer Cell 22(6):737-750.
29. Guerra C, et al. (2007) Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice. Cancer Cell 11(3):291-302. (Pubitemid 46349841)
30. Fendrich V, et al. (2008) Hedgehog signaling is required for effective regeneration of exocrine pancreas. Gastroenterology 135(2):621-631.
31. Apelqvist A, Ahlgren U, Edlund H (1997) Sonic hedgehog directs specialised mesoderm differentiation in the intestine and pancreas. Curr Biol 7(10):801-804. (Pubitemid 27441836)
32. Aguirre AJ, et al. (2003) Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. Genes Dev 17(24):3112-3126. (Pubitemid 38040774)
33. Bai CB, Auerbach W, Lee JS, Stephen D, Joyner AL (2002) Gli2, but not Gli1, is required for initial Shh signaling and ectopic activation of the Shh pathway. Development 129(20):4753-4761. (Pubitemid 35277202)
34. Sastra SA, Olive KP (2013) Quantification of murine pancreatic tumors by high-resolution ultrasound. Methods Mol Biol 980:249-266.
35. Foygel K, et al. (2013) Detection of pancreatic ductal adenocarcinoma in mice by ultrasound imaging of thymocyte differentiation antigen 1. Gastroenterology 145(4):885-894, e3.
36. Brunton SA, et al. (2009) Potent agonists of the Hedgehog signaling pathway. Bioorg Med Chem Lett 19(15):4308-4311.
37. Whatcott CJ, Posner RG, Von Hoff DD, Han H (2012) Desmoplasia and chemoresistance in pancreatic cancer. Pancreatic Cancer and Tumor Microenvironment, eds Grippo PJ, Munshi HG (Transworld Research Network, Trivandrum, India).
38. Apte MV, et al. (2004) Desmoplastic reaction in pancreatic cancer: Role of pancreatic stellate cells. Pancreas 29(3):179-187. (Pubitemid 39304974)
39. Mollenhauer J, Roether I, Kern HF (1987) Distribution of extracellular matrix proteins in pancreatic ductal adenocarcinoma and its influence on tumor cell proliferation in vitro. Pancreas 2(1):14-24.
40. Imamura T, et al. (1995) Quantitative analysis of collagen and collagen subtypes I, III, and V in human pancreatic cancer, tumor-associated chronic pancreatitis, and alcoholic chronic pancreatitis. Pancreas 11(4):357-364.
41. Rhim AD, et al. (2014) Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma. Cancer Cell 25(6):735-747.
42. Ozdemir BC, et al. (2014) Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell 25(6):719-734.
43. Kosinski C, et al. (2010) Indian hedgehog regulates intestinal stem cell fate through epithelial-mesenchymal interactions during development. Gastroenterology 139(3):893-903.
44. van Dop WA, et al. (2010) Loss of Indian Hedgehog activates multiple aspects of a wound healing response in the mouse intestine. Gastroenterology 139(5):1665-1676, e1-e10.
45. Provenzano PP, et al. (2012) Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma. Cancer Cell 21(3):418-429.
46. Provenzano PP, Hingorani SR (2013) Hyaluronan, fluid pressure, and stromal resistance in pancreas cancer. Br J Cancer 108(1):1-8.
47. Kawaguchi Y, et al. (2002) The role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors. Nat Genet 32(1):128-134. (Pubitemid 34977207)
48. Jackson EL, et al. (2001) Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev 15(24):3243-3248. (Pubitemid 34008190)
49. Lewis PM, et al. (2001) Cholesterol modification of sonic hedgehog is required for long-range signaling activity and effective modulation of signaling by Ptc1. Cell 105(5):599-612. (Pubitemid 32524113)
50. Jonkers J, et al. (2001) Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nat Genet 29(4):418-425. (Pubitemid 34326692)
51. Serrano M, et al. (1996) Role of the INK4a locus in tumor suppression and cell mortality. Cell 85(1):27-37. (Pubitemid 26116804)